Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venglustat + imiglucerase in type 3 Gaucher disease (II/III, LEAP2IT China)
CTR20210730Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venglustat in Gaucher disease type 3, sponsored by Sanofi. Started Apr 2021; status: terminated.
02
Drugs
venglustat
03
Conditions
Gaucher disease type 3
Beyond the preview
Go deeper on CTR20210730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210730.